Cathetrix will launch Nephro-Safe, the world's most advanced nephrostomy tube stabilizer, and will showcase, Foley-Safe, the world's first Foley catheter stabilizer with active protection.

such as drug-coated balloon angioplasty and stent placement. "FDA clears InterVene’s in-stent restenosis catheter" was originally created and published by Medical Device Network, a GlobalData owned ...

A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis ...

A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis ...

Orchestra BioMed (Nasdaq:OBIO) announced today that it entered into a termination and right of first refusal agreement with ...

The global Occlusion Balloon Catheter Market, valued at USD 1.3 billion in 2025, is forecast to reach USD 3.1 billion by 2035 ...

The interventional approach to treat peripheral artery occlusive disease (PAOD) as a treatment of choice is gaining continuous acceptance. SeQuent ® Please OTW offers a targeted, polymer-free and ...

October 15, 2025—Crossroads Neurovascular Inc. announced findings from the early clinical experience of the Path balloon guide catheter (BGC) during its ongoing limited market release (LMR) phase. The ...

Background Peripheral artery disease (PAD) represents a significant global health burden. Percutaneous transluminal angioplasty (PTA) is the most commonly employed endovascular intervention; however, ...